Nuysy,over the years I’ve spoken with Board members and highly qualified scientists. (Biotech for one)
Should it be reverse engineering that you seek assurance of, I’ve been satisfied by explanations indicating that is difficult.
Should it be cost of the product that concerns you, once again previous assurances of low cost was confirmed at the recent Sydney presentation.
There are interesting options for Anteo to generate their income stream from:
Clipping the ticket with royalties, or directly from a gross profit margin for the supply of the patented Anteocoat etc.
the flexibility offered to ADO is one of many positives I, together with others took from the presentation and the opportunity to explore these concerns.
Since that meeting, sufficient time has passed for shareholders to explore and evaluate serious uptake on the range of interest in Energy and POC markets for a very interesting Sydney AGM 16th November. GLTA
